Fingerprint
Dive into the research topics of 'Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
Cecilia Monge, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M. Hernandez, Bradford J. Wood, Elliot B. Levy, Israa Juburi, Stephen M. Hewitt, David E. Kleiner, Seth M. Steinberg, William D. Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G. Duffy, Tim F. Greten*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review